Having trouble accessing articles? Reset your cache.

HDAC3 identified as obesity target

DISEASE CATEGORY: Endocrine/metabolic

INDICATION: Obesity

Intestinal HDAC3 inhibition could treat obesity. In

Read the full 107 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE